Sutton Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-322
| Closed | -$21.5K | – | 1218 |
|
|
2022
Q4 | $21.5K | Sell |
322
-194
| -38% | -$13K | 0.01% | 669 |
|
|
2022
Q3 | $27.7K | Buy |
516
+1
| +0.2% | +$54 | 0.01% | 548 |
|
|
2022
Q2 | $28.6K | Hold |
515
| – | – | 0.01% | 543 |
|
|
2022
Q1 | $36.1K | Buy |
515
+175
| +51% | +$12.3K | 0.01% | 510 |
|
|
2021
Q4 | $32.7K | Sell |
340
-83
| -20% | -$7.99K | 0.01% | 545 |
|
|
2021
Q3 | $36.8K | Buy |
+423
| New | +$36.8K | 0.01% | 493 |
|
|
2018
Q4 | – | Sell |
-470
| Closed | -$80.4K | – | 1166 |
|
|
2018
Q3 | $80.4K | Buy |
470
+72
| +18% | +$12.3K | 0.05% | 220 |
|
|
2018
Q2 | $51.4K | Hold |
398
| – | – | 0.04% | 279 |
|
|
2018
Q1 | $41K | Hold |
398
| – | – | 0.03% | 326 |
|
|
2017
Q4 | $34K | Hold |
398
| – | – | 0.02% | 379 |
|
|
2017
Q3 | $33.8K | Hold |
398
| – | – | 0.03% | 371 |
|
|
2017
Q2 | $30.1K | Buy |
398
+66
| +20% | +$4.99K | 0.02% | 395 |
|
|
2017
Q1 | $21.9K | Hold |
332
| – | – | 0.02% | 489 |
|
|
2016
Q4 | $21K | Hold |
332
| – | – | 0.02% | 476 |
|
|
2016
Q3 | $21.1K | Hold |
332
| – | – | 0.02% | 447 |
|
|
2016
Q2 | $24.7K | Hold |
332
| – | – | 0.02% | 391 |
|
|
2016
Q1 | $22.2K | Buy |
+332
| New | +$22.2K | 0.02% | 413 |
|